Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Blanco

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Ophthalmology|January 19, 2020
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study GroupVictor Llorenç, Miguel Cordero-Coma, Ana Blanco-Esteban, et al.
European Radiology|December 8, 2020
Correction to: The practice of emergency radiology throughout Europe: a survey from the European Society of Emergency Radiology on volume, staffing, equipment, and schedulingMariano Scaglione, Raffaella Basilico, Andrea Delli Pizzi, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Breast Cancer Research and Treatment|November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerAna Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Scientific Reports|December 17, 2022
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genesAntoni E Bordoy, Verónica Saludes, David Panisello Yagüe, et al.
The British Journal of Ophthalmology|January 18, 2015
Specific association of IL17A genetic variants with panuveitisArkaitz Mucientes, Ana Márquez, Miguel Cordero-Coma, et al.
Seminars in Arthritis and Rheumatism|June 21, 2015
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patientsLeyre Riancho-Zarrabeitia, Vanesa Calvo-Río, Ricardo Blanco, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodiesDavid Sánchez-Martín, Jorge Martínez-Torrecuadrada, Tambet Teesalu, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Ophthalmology|January 19, 2020
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study GroupVictor Llorenç, Miguel Cordero-Coma, Ana Blanco-Esteban, et al.
European Radiology|December 8, 2020
Correction to: The practice of emergency radiology throughout Europe: a survey from the European Society of Emergency Radiology on volume, staffing, equipment, and schedulingMariano Scaglione, Raffaella Basilico, Andrea Delli Pizzi, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Breast Cancer Research and Treatment|November 5, 2011
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancerAna Blanco, Miguel de la Hoya, Judith Balmaña, et al.
Scientific Reports|December 17, 2022
Monitoring SARS-CoV-2 variant transitions using differences in diagnostic cycle threshold values of target genesAntoni E Bordoy, Verónica Saludes, David Panisello Yagüe, et al.
The British Journal of Ophthalmology|January 18, 2015
Specific association of IL17A genetic variants with panuveitisArkaitz Mucientes, Ana Márquez, Miguel Cordero-Coma, et al.
Seminars in Arthritis and Rheumatism|June 21, 2015
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patientsLeyre Riancho-Zarrabeitia, Vanesa Calvo-Río, Ricardo Blanco, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodiesDavid Sánchez-Martín, Jorge Martínez-Torrecuadrada, Tambet Teesalu, et al.
Pageof 13